Lijian Tao
- Nephrology top 1%
- Chronic Kidney Disease and Diabetes 17
- Acute Kidney Injury Research 11
- Renal Diseases and Glomerulopathies 7
- Physiology top 5%
- Immunology top 5%
- Hepatology top 5%
- Liver physiology and pathology 8
- Obstetrics and Gynecology top 5%
-
- Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis 14
-
- Liver Disease Diagnosis and Treatment 10
-
- Inflammasome and immune disorders 9
-
- Sulfur Compounds in Biology 7
- Cited by
- NephrologyPhysiologyImmunology
- Journals
- Nature Medicine (2 papers)SHILAP Revista de lepidopterología (1 paper)The Journal of Immunology (1 paper)
- Partner nations
- ChinaUnited StatesCanada
In The Last Decade
Lijian Tao
143 papers receiving 3.1k citations
Peers
Comparison fields: 5 of 126
- Nephrology 472
- Physiology 101
- Immunology 454
- Hepatology 150
- Obstetrics and Gynecology 133
Countries citing papers authored by Lijian Tao
This map shows the geographic impact of Lijian Tao's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Lijian Tao with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Lijian Tao more than expected).
Fields of papers citing papers by Lijian Tao
This network shows the impact of papers produced by Lijian Tao. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Lijian Tao. The network helps show where Lijian Tao may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Lijian Tao, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 4 | |
| 2 | 2024 | 3 | |
| 3 | 2024 | 7 | |
| 4 | 2023 | 11 | |
| 5 | 2023 | 40 | |
| 6 | 2022 | 22 | |
| 7 | 2022 | 13 | |
| 8 | 2020 | 47 | |
| 9 | 2020 | 26 | |
| 10 | 2019 | 19 | |
| 11 | 2019 | 11 | |
| 12 | 2018 | 12 | |
| 13 | 2018 | 10 | |
| 14 | 2018 | 17 | |
| 15 | NRBP1 is downregulated in breast cancer and NRBP1 overexpression inhibits cancer cell proliferation through Wnt/β-catenin signaling pathway | 2015 | 3 |
| 16 | 2015 | 22 | |
| 17 | 2014 | 10 | |
| 18 | 2012 | 162 | |
| 19 | Effect of enalapril on early stage of renal interstitial fibrosis in rats | 2009 | 1 |
| 20 | 2007 | 4 |
About Lijian Tao
Lijian Tao is a scholar working on Nephrology, Hepatology and Pulmonary and Respiratory Medicine, having authored 148 papers that have together received 3.1k indexed citations. Recurring topics across this work include Chronic Kidney Disease and Diabetes (17 papers), Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis (14 papers), Acute Kidney Injury Research (11 papers), Liver Disease Diagnosis and Treatment (10 papers), Inflammasome and immune disorders (9 papers), Liver physiology and pathology (8 papers), Sulfur Compounds in Biology (7 papers) and Renal Diseases and Glomerulopathies (7 papers). The work is most often cited by research in Nephrology (472 citations), Physiology (101 citations) and Immunology (454 citations). Lijian Tao has collaborated with scholars based in China, United States and Canada. Frequent co-authors include Zhangzhe Peng, Gaoyun Hu, Yanyun Xie, Jie Meng, Qiongjing Yuan, Damu Tang, Yang Xia, Rodney E. Kellems, Jian Zhang and Nasui Wang. Their work appears in journals such as Nature Medicine, SHILAP Revista de lepidopterología and The Journal of Immunology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.